SpaceX Raptor 2 Engines

SpaceX Raptor 2 engines were achieving 230 tf (510,000 lbf) of thrust consistently by February 2022. SpaceX is tuning engine parameters and design to achieve at least 250 tf (550,000 lbf). Elon Musk indicated that the engine production cost was approximately half that of the Raptor 1 version SpaceX had been using in 2018–2021. SpaceX…
SpaceX Raptor 2 Engines


SpaceX Raptor 2 engines were achieving 230 tf (510,000 lbf) of thrust consistently by February 2022. SpaceX is tuning engine parameters and design to achieve at least 250 tf (550,000 lbf). Elon Musk indicated that the engine production cost was approximately half that of the Raptor 1 version SpaceX had been using in 2018–2021. SpaceX is aiming for the cost-per-tonne of thrust of each Raptor to be under $1,000 — so around $250,000 to produce.

SpaceX is building one Raptor 2 engine per day and the factory has the capacity to reach about four engines per day.

SpaceX completed Starship Flight Test mission in April 20, 2023. The Super Heavy had 33 Raptor 2 engines during the launch but 3 of those had already failed by the time the rocket started to lift from the launchpad.

Starship Raptor V1 vs. Raptor V2 = More power, less parts.

SpaceX is working to rapidly improve the Starship launch vehicle and make manufacturing cost-effective. The company has been able to achieve this with the rocket engines’ development.

Raptors are fueled by ‘Methalox’,… pic.twitter.com/vvwKgHzN76

— Evelyn Janeidy Arevalo (@JaneidyEve) May 8, 2023

SpaceX has two Raptor engine factories.

Phase I of the second factory was an investment of $100 million in real and personal property improvements by June 30, 2024, along with a minimum of 250 new full-time jobs by June 30, 2025.

The city-county EDC provided a Phase I incentive of $4 million.

Phase II will require the company to invest another $50 million in real and personal property improvements by June 30, 2025, along with a minimum of 150 new full-time jobs and Phase I facility investment by June 30, 2026.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
NuScale Plans $1.9 Billion Merger to Make Small Modular Reactors
Read More

NuScale Plans $1.9 Billion Merger to Make Small Modular Reactors

NuScale Power plans to merge with Spring Valley Acquisition Corp to create a new “first of its kind” energy company to accelerate the commercialization of NuScale’s small modular reactor (SMR). The new publicly listed company will be named NuScale Power Corporation. NuScale’s proprietary NuScale Power Module is a pressurised water reactor with all the components…
NASA Extracts Oxygen from Lunar Soil Simulant
Read More

NASA Extracts Oxygen from Lunar Soil Simulant

One of NASA’s primary goals is to establish a long-term presence on the lunar surface. Oxygen is a crucial building blocks for making that vision a reality. Oxygen is used for breathing nad can also be used as a propellant for transportation. Scientists at NASA’s Johnson Space Center in Houston successfully extracted oxygen from simulated…
Modular Molten Salt Reactors Starting 2028
Read More

Modular Molten Salt Reactors Starting 2028

Late in 2021, Terrestrial Energy has unveiled an upgraded 390-MWe design of its Integral Molten Salt Reactor (IMSR®) power plant to meet utility requirements and boost its cost-competitiveness as part of an effort to ramp up its candidacy for deployment at Ontario Power Generation’s (OPG’s) Darlington Nuclear Generating Station. Terrestrial Energy announced a series of…
Complete Remission in All 12 Colorectal Phase 2 Cancer Trial Patients
Read More

Complete Remission in All 12 Colorectal Phase 2 Cancer Trial Patients

A total of 12 patients have completed treatment with dostarlimab and have undergone at least 6 months of follow-up. All 12 patients (100%; 95% confidence interval, 74 to 100) had a clinical complete response, with no evidence of tumor on magnetic resonance imaging, 18F-fluorodeoxyglucose–positron-emission tomography, endoscopic evaluation, digital rectal examination, or biopsy. At the time…